跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Phosphatidylinositol
首页
药物
Phosphatidylinositol
Phosphatidylinositol
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA
EP 3943494 A1
申请人: ICOS CORP
优先权: 2004
CN
EP
US
22 件公开
Inhibitors of human phosphatidyl-inositol 3-kinase delta
US 6949535 B2
申请人: ICOS CORP
优先权: 2001
CN
US
20 件公开
INTERMEDIATE PRODUCTS IN PROCESS METHODS FOR THE PREPARATION OF PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS
EP 3594215 A1
申请人: GILEAD CALISTOGA LLC
优先权: 2013
CN
EP
US
8 件公开
Phosphatidylinositol 3-kinase inhibitors and methods of their use
US 7989622 B2
申请人: EXELIXIS INC
优先权: 2005
CN
EP
US
7 件公开
ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE
EP 3808739 A1
申请人: VERTEX PHARMA
优先权: 2009
EP
US
7 件公开
Inhibitors of phosphatidylinositol 3-kinase
US 2007032487 A1
申请人: BRUCE IAN
优先权: 2003
CN
US
6 件公开
US 8344153 B2
申请人: VERTEX PHARMA
优先权: 2010
CN
US
3 件公开
US 2011135603 A1
申请人: VERTEX PHARMA
优先权: 2009
CN
US
2 件公开
Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
US 7893060 B2
申请人: HOFFMANN LA ROCHE
优先权: 2007
CN
US
5 件公开
NEW INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE
EP 4608509 A1
申请人: INST NAT SANTE RECH MED
优先权: 2022
CN
EP
US
WO
4 件公开
PEPTIDE COMPOSITIONS TARGETING GLYPICAN-3 AND USES THEREOF
EP 4724459 A1
申请人: PEPTIDREAM INC
优先权: 2023
CN
EP
US
WO
4 件公开
Inhibitors of human phosphatidylinositol 3-kinase delta
US 6518277 B1
申请人: ICOS CORP
优先权: 2001
CN
US
4 件公开
第 1 / 9 页
上一页
下一页
药物
反馈